Search

everythinglearnresearchcommunity

for

Search:↓

Drugs targeting the JAK/STAT pathway can improve atopic dermatitis but vary in effectiveness for vitiligo and alopecia areata, with generally mild safety concerns.

Early and personalized treatment for hair loss in young people is crucial to prevent permanent damage and should include psychological support.

Genetic differences affect COVID-19 severity and treatment development.

Certain fats in the skin help control inflammation and health, and changing these fats through diet or supplements might treat skin inflammation.

Monochromatic light devices, especially the 308-nm excimer laser, are promising for treating alopecia areata but more research is needed.

Stem cell technologies and regenerative medicine, including platelet-rich plasma, show promise for hair restoration in treating hair loss, but more research is needed.

Understanding how epigenetic regulation affects stem cells is key to cancer insights and new treatments.

Natural plant products like Proanthocyanidins and curcumin may help treat ischemic stroke by reducing inflammation.

The new FDA labeling rules provide more detailed drug safety information for pregnant and breastfeeding women, but more data is needed on the risks of many dermatologic drugs.

New hair loss treatments may include topical medications, injections, and improved transplant methods.

Higher Lnk protein levels in ovaries may lead to insulin resistance in women with PCOS.

Local corticosteroids can help with alopecia areata, but hair loss often returns after stopping treatment.

The guidelines offer updated treatment recommendations for alopecia areata in Korea using topical and device-based methods.

Combining baricitinib with UV-B therapy effectively treats non-segmental vitiligo and is well-tolerated.

Chronic inflammatory skin diseases are caused by disrupted interactions between skin cells and immune cells.

lncRNAs are important for understanding and treating skin diseases.

Corticosteroids are the most common treatment for alopecia areata, but many patients need better options.

The document concludes that various dermatological treatments and drugs can cause skin reactions and side effects.

Different types of alopecia cause hair loss due to immune system issues, with some allowing regrowth and others causing permanent loss.

Ritlecitinib is effective and safe for long-term use in treating severe alopecia areata in people aged 12 and older.

In 2024, the FDA approved 50 new drugs, including treatments for hair loss, anemia, high blood pressure, and Alzheimer's.

64 drugs can cause hair loss, needing better monitoring and updated labels.

Alopecia Areata significantly lowers quality of life and current treatments are inadequate, highlighting a need for better therapies and standardized treatment protocols.

Ritlecitinib is safe and well-tolerated for treating alopecia areata in patients aged 12 and older.

COVID-19 can cause skin problems and affect dermatology treatments, with recommendations for skin care and cautious use of certain drugs.

There are many treatments for common hair loss, but more trials are needed to decide which are best.

Vimentin is crucial for wound healing, cell growth, and managing immune responses.

ILC1-like cells can cause alopecia areata by attacking hair follicles.

Most patients with rheumatoid arthritis continued methotrexate treatment over two years, but those who stopped and restarted experienced more side effects and less improvement.

Up to half of people experience itchy scalp, often due to skin conditions like seborrheic dermatitis or psoriasis, and treatments vary based on the specific cause.